Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 2FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Glioblastoma 473Brain Neoplasms 306Glioma 257Neoplasms 122Astrocytoma 88Carcinoma, Non-Small-Cell Lung 77Breast Neoplasms 70Neuroblastoma 65Central Nervous System Neoplasms 61Melanoma 58Recurrence 46Lung Neoplasms 45Pancreatic Neoplasms 41Oligodendroglioma 37Ovarian Neoplasms 36Colorectal Neoplasms 36Neoplasm Metastasis 33Sarcoma 32Medulloblastoma 28Stomach Neoplasms 27Gliosarcoma 27Lymphoma 25Prostatic Neoplasms 24Head and Neck Neoplasms 24Neurofibromatosis 1 23Rhabdomyosarcoma 21Neurofibroma, Plexiform 19Esophageal Neoplasms 19Diffuse Intrinsic Pontine Glioma 19Cholangiocarcinoma 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Hearing Loss × CNS × Clear all
NCT06517888 2026-04-06

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Akouos, Inc.

Phase 1/2 Recruiting
27 enrolled
CNS

Neuroma, Acoustic, Hearing Loss

NCT07503613 2026-04-06

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Akouos, Inc.

Enrolling by invitation
100 enrolled
CNS

Neuroma, Acoustic, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡